Skip to content
10-Q

Quarterly Report

LifeStance Health Group, Inc. LFST

0001193125-25-269712

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 29, 2025 389M sh
Shares Diluted Q3 2025 · Sep 30, 2025 388.9M sh
Shares Diluted Q3 2025 · Sep 30, 2025 385.67M sh
Shares Diluted Q3 2025 · Sep 30, 2024 380.36M sh
Shares Diluted Q3 2025 · Sep 30, 2024 378.71M sh
Capex Q3 2025 · Sep 30, 2025 $25.21M
Capex Q3 2025 · Sep 30, 2024 $15.27M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $88.59M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $44.94M
Long Term Debt Q3 2025 · Sep 30, 2025 $269.39M
Long Term Debt Q3 2025 · Dec 31, 2024 $279.79M
Short Term Debt Q3 2025 · Sep 30, 2025 $12.69M
Short Term Debt Q3 2025 · Dec 31, 2024 $7.25M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $203.9M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $154.57M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.49B
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.45B
Current Liabilities Q3 2025 · Sep 30, 2025 $228.56M
Current Liabilities Q3 2025 · Dec 31, 2024 $228.89M
Total Liabilities Q3 2025 · Sep 30, 2025 $656.23M
Total Liabilities Q3 2025 · Dec 31, 2024 $672.01M
Current Assets Q3 2025 · Sep 30, 2025 $360.38M
Current Assets Q3 2025 · Dec 31, 2024 $312.51M
Total Assets Q3 2025 · Sep 30, 2025 $2.15B
Total Assets Q3 2025 · Dec 31, 2024 $2.12B
Sga Expense Q3 2025 · Sep 30, 2025 $95.62M
Sga Expense Q3 2025 · Sep 30, 2025 $287.42M
Sga Expense Q3 2025 · Sep 30, 2024 $85.27M
Sga Expense Q3 2025 · Sep 30, 2024 $269.36M
Net Income Q3 2025 · Sep 30, 2025 $1.08M
Net Income Q3 2025 · Sep 30, 2025 −$2.01M
Net Income Q3 2025 · Sep 30, 2024 −$5.96M
Net Income Q3 2025 · Sep 30, 2024 −$50.33M
Operating Income Q3 2025 · Sep 30, 2025 $7.41M
Operating Income Q3 2025 · Sep 30, 2025 $6.06M
Operating Income Q3 2025 · Sep 30, 2024 $47K
Operating Income Q3 2025 · Sep 30, 2024 −$32.67M